Amy is an experienced professional with over 7 years in a CRO environment and a strong background in GMP-regulated laboratories. She has proven expertise across all phases of bioassay development—from cell culture and assay execution to data interpretation, with a secondment to R&D contributing to the development of the IndEx-2 cell platform system.
This comprehensive, hands-on experience enables Amy to have a meticulous and informed approach to study management, with a strong attention to detail at every stage of the bioassay lifecycle.